Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Exec. VP, Operations | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,984 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Exercise / conversion · Acquired 3,000 · Balance 70,984 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $166.73 · Expires 2026-10-27 | Direct | 3,028 |
Reported balance
After 2026-10-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-12 · Exercise / conversion · Disposed 3,000 · Balance 3,028 F1: The option vested in full on October 27, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vested in full on October 27, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2021 Filed Apr 29, 2021 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,028 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001567619-21-008751 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,028 Underlying: Common Stock · 23,028 shares Expires 2026-10-27 F1 · derivative.exercise_date: The Option vests on October 27, 2025, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:05 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,211 | $167.00 | $1,037,237.00 |
DisclosureSEC source: 0001567619-21-005738 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,005 Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17,037 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-019061 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,037 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on July 7, 2014 and vested in four annual installments of approximately 25% on each grant date anniversary. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 17,037 | $14.41 | $245,503.17 |
DisclosureSEC source: 0001567619-20-019061 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-017753 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,037 Underlying: Common Stock · 20,000 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on July 7, 2014 and vested in four annual installments of approximately 25% on each grant date anniversary. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 20,000 | $14.41 | $288,200.00 |
DisclosureSEC source: 0001567619-20-017753 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,000 | $126.00 | $882,000.00 |
DisclosureSEC source: 0001567619-20-014633 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,179 Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 19:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,000 | $121.14 | $726,840.00 |
DisclosureSEC source: 0001567619-20-014140 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,179 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:48 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,984 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001567619-20-005461 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,984 Underlying: Common Stock · 50,984 shares Expires 2026-02-28 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:48 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantCommon Stock | 7,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005461 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,179 Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001567619-19-015934 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-08-05 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:44 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 25,185 | $59.91 | $1,508,833.35 |
DisclosureSEC source: 0001567619-18-003372 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,396 F1 · kind: Represents the receipt of MEDP shares in an in-kind distribution by Medpace Investors, LLC ("MPI") to the Reporting Person in exchange for the Reporting Person's Incentive Units of MPI. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:01 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001140361-18-011626 · doc1.xml · derivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-02-28 F1 · derivative.exercise_date: The option vests on February 28, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 18:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 20,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001209191-17-021292 · doc4.xml · derivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: COMMON STOCK · 20,000 shares Expires 2024-03-15 F1 · derivative.exercise_date: The option vests on March 15, 2021, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.